List of Vendor Companies in India - 67

ADEPT PHARMA AND BIOSCIENCE EXCELLENCE PRIVATE LIMITED is a mining & metals company based out of 10-3-561/3/A/102, Vijaya Nagar Colony, Asif Nagar,, Hyderabad, Telangana, India.

Welcome to Advaita, where innovation meets expertise in B2B services. Our expertise lies in 360 degrees solutions to your corporate needs. We specialise in Corporate Events, Corporate training, Data analysis based AI solutions, Market Research, Analytics, Business consulting, Networking and Partnerships. We are a technology driven organization and keep ourselves up to date with the changing trends and market needs. At Advaita, we understand that each client is unique, and our services are tailored to meet your specific needs.

Algorithmic Biologic's vision is to create a bountiful and healthy world by bringing scale efficiencies to molecular discovery and diagnostics. Our transdisciplinary team has a deep modeling-based understanding of the chemistry and mechanics of molecular technologies. Our first product, Tapestry, is award-winning, regulatory approved algorithmic solution to provide affordable large-scale COVID-19 testing.

Since 1978, Appasamy Associates and Group of companies have been leading manufacturers and distributors of Ophthalmic Diagnostic & Surgical Equipments, Intraocular Lenses (IOLs), Microsurgical Instruments and Ophthalmic Pharmaceuticals. Our four decades of work have been widely appreciated throughout the world. Our dedication to support our products had become a bench mark among the community. We have dedicated R & D team to fulfil state of the art requirements of the ophthalmic community. We strive hard to make each and every modern technology and equipment within the easy reach of ophthalmic surgeons and visions care professionals in India. Our various manufacturing facilities at Chennai, Pondicherry and Baddi have got quality systems certifications audited by TUV, DNV and ITC for ISO 9000 and ISO 13485 requirements. The certifications bodies also provided CE marking for various products.

Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, we transform your ideas into solutions for better health. Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement. At Aragen, we recognize your work is vital, urgent and impacts lives. Our purpose, ‘In every molecule is the possibility for better health’ motivates us to drive the success of your programs, so that we can together transform hope into health for millions of people around the world.

ArrayGen Technologies is a India based Genomics Service provider. The organization was formed in 2014 and has been providing services to clients in India and overseas. We are a continously growing firm with an enthusiastic team dedicated to fullfil all your needs in bioinformatics. We belive in delivering the best and our services persue our motto. We also expertise in online and offline training and workshops. These trainings help the undertaker to gain industrial experience and knowledge that can help them on a great career path in the fields of bioinformatics. Our services specialize in algorithm development,array design, microarray data analysis, NGS data analysis, clinical genomics services, Agrigenomics services, bioinformatics services. ArrayGen's service expands to many international countries including United Kingdom, Israel , United Arab Emirates, Egypt, Jordon etc. In the year 2016, ArrayGen plans to introduce Summer Internships for international and national students. ArrayGen aims to a place you can find all the solutions to your problems....!!!

Avesthagen Limited - Brief Summary Avesthagen is a leading systems biology life science company uniquely positioned to help solve some of the world's biggest healthcare and environmental challenges. Since its inception 20 years ago, Avesthagen has introduced new ideas, technologies, and products, for the life sciences market. The Avestagenome Project® is Avesthagen's largest epidemiological study ever conducted in India, and the first such detailed system biology study worldwide on an endogamous population. The project has collected a biobank of Parsi blood samples with extensive patient data from 4,500 members and investigates the molecular basis of longevity and age-related disorders, prioritizing cancers, cardiovascular disease, diabetes and neurological disorders. Recognizing the importance of the Parsi cohort and the unique systems' biology approach to research, the U.S.-based Foundation for a Smoke-Free World, whose mission is to end smoking within this generation, recently awarded a grant to Avesthagen Limited® to prioritize research into lung and tobacco-related cancers. Avesthagen will combine liquid biopsy, next-generation sequencing (NGS), state- of-the-art bioinformatics, artificial intelligence and machine learning to identify predictive and early-stage biomarkers of cancers in smokers. The project will use non-Parsi smoker and non-smoker samples from the wider Indian and other populations to gain further insights into the evidence behind such data. Avesthagen is expected to be a key player in the lucrative personalised medicine market, which is projected to reach a value of US $1.7 trillion by 2026. Today, Avesthagen is proud to build on this heritage by partnering with others to tackle unprecedented challenges now facing our world. We believe we can provide enough healthy food for people everywhere and protect the environment for generations to come.

Beta Drugs Ltd. is a dedicated world leader in oncology. BDL is a Global leader in the development of enabling products, scientific knowledge, and technical expertise within a wide range of applications. At Beta DrugsLtd. (BDL.) we are improving both the speed to market of our products and the value of our product introductions to customers. Inspired by a newly-formed breakthrough innovation group, Beta Drugs Ltd. (BDL.) is actively exploring opportunities that stretch business and technology boundaries.

Bilcare is market leader in pharma packaging, packaging innovation and research that partners with the pharmaceutical industry to improve patient health-care outcomes. We endeavor to deliver effective and affordable solutions that enhance the speed and quality of drug discovery and help build and protect brands by ensuring the delivery of genuine medicines to patients. Bilcare PPI offers Innovative Pharmaceutical Packaging Solutions comprising of a wide range of specialty Polymer Films and Aluminum Foils mainly used for packaging of solid dosage pharmaceutical products. Bilcare GCS provides Global Clinical Material Supplies for new drug discovery projects. Bilcare Technologies provides track and trace, authentication and Anti-counterfeit (nCID - nonclonableID) solutions for product & people ID authentication and security. Our other packaging films solutions cater to various industries which includes ID Card industry, Specialty Films Applications and Food packaging. Bilcare's philosophy involves working closely with our customers to develop packaging solutions addressing mainly the core challenges of the pharmaceutical companies --commonly known in Bilcare as "5 Cs" viz. Compliance – directions of dosage administration, Counterfeiting – deterring piracy and counterfeit in medicines packaging; Communication – differentiating and brand recall strategies; Convenience – smart and easy to carry, dispensing; Child Resistant Packaging – to avoid accidental misuse by children). These comprehensive Innovative Packaging Solutions backed with technology helps our Pharma customers to secure and grow their brand in the global market. Bilcare's multiple manufacturing and R&D facilities on Innovative Pharma Packaging Solutions are spread across in Europe, USA and Asia. These facilities together with our global sales force makes us reach and serve our customers to over 100 countries with our wide range products and services.

Biodeal Pharma is a WHO-GMP Certified and PIC/S approved pharmaceutical manufacturing Company and is a highly respected name as a fully integrated Indian Manufacturing Company located amidst the green fields of Himachal Pradesh and are leading global providers in Pharmaceuticals, Cosmetics and Nutraceuticals. Owing to persistent values of customer satisfaction, unsurpassed quality standards, human safety, innovation and serves a clientele of more than 30 reputed companies like TORRENT, DRL, SUN PHARMA, DR. MOREPEN, CADILA, ZYDUS, ALEMBIC, ALKEM, WOCKHARDT, INTAS, ZUVENTUS, IPCA, INDOCO, MACLEODS , KOYE PHARMA, ERIS LIFESCIENCES , AJANTA PHARMA, etc. BIODEAL offers Products on Third Party Basis for Export as well as Domestic business on contract manufacturing basis. Our Sections:- • Tablets (Drugs & Nutraceuticals) • Capsules (Drugs & Nutraceuticals) • Dry Powder Inhaler Capsules • Oral Spray (Food) • Dry Sachet • Dusting Powder • Nasal Sprays • Lotion • Ointment • Cosmetics Biodeal has a strong presence in NUTRACEUTICALS with VITAGEN, offering Vitamins, Multi complex, Antioxidants, Amino acids, Omegas, Herbals and varied categories to meet specific needs. Besides most common tablet or capsule formats, VITAGEN offers the biggest range of innovative delivery forms which are easy to consume and have a great taste, e.g., Spray, Chewable, Sachets. The large number of bioavailable and well absorbed products provides the opportunity for everyone to be able to get a Nutrition therapy according to individual needs. Also introducing all new range of VITAGEN Sunscreens, specifically developed formulations for sun protection and skin care. Vegetarian prebiotic capsule is used in all the products, which are generally better consumed by digestive system, and ideal for those who do not want to take animal gelatin for moral, diet or religious reason, as well as opting for a healthier alternative.

Biodimension is offering biofabricated human tissues as an efficient animal alternative testing solutions to pharma companies for more efficient drug screening and toxicity testing. We leverage biofabrication technology to develop our 3D biofabricated human tissue models.

Biosense is among the leading Point of Care Testing and Instrumentation companies in India. Biosense Technologies is part of the Tulip Diagnostics, a Perkin Elmer Company. For more, visit our website www.biosense.in

Founded by Shri I.A. Modi, Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, in the State of Gujarat. Over the last seven decades, the company has been developing and manufacturing pharmaceutical products in India and selling and distributing these in over hundred other countries around the world. Focused strongly on Innovation and Research, the company is present in more than forty-five therapeutic areas spread across twelve specialities, including cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics and immunologicals. At Cadila Pharmaceuticals, Research and Development is at the core of all its initiatives, be it Biotechnology, APIs, Formulations, Plant Tissue Culture or Phytochemistry. More than 300 scientists in its various Research and Development setups reinforce the competitiveness of research in the therapeutic areas which have high unmet medical needs. Cadila Pharmaceuticals Excellence in manufacturing facilities is central to Cadila Pharmaceuticals. The company’s formulations manufacturing plant at Dholka near Ahmedabad, Gujarat is spread over hundred acres of land. This state-of-the- art facility is not only impressive in size, but is also USFDA approved. The second formulations manufacturing facility is located at Samba in Jammu and Kashmir. The facility meets most of the stringent quality standards across the globe to produce tablets, capsules, soft and hard gelatin capsules, liquids and orals. Two Active Pharmaceutical Ingredient (API) manufacturing units at Ankleshwar, Gujarat manufacture a wide range of APIs and intermediates including many USFDA-certified products. The company has strong foothold in the African continent through its formulation manufacturing facility at Addis Ababa in Ethiopia. For more information visit: https://www.cadilapharma.com/

Calyx Chemicals & Pharmaceuticals Ltd. is a manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates, based in India. With over 40 years of experience, the company operates a US FDA-inspected facility in Tarapur, Maharashtra. It specializes in APIs for anti-TB and anti-malarial therapeutic areas and offers custom synthesis of pharmaceutical intermediates. Calyx provides integrated services through its Contract Research and Manufacturing Services (CRAMS), which encompass API development and contract manufacturing. The company has a strong regulatory compliance record, having successfully passed audits from USFDA, EDQM, and WHO. It serves a global customer base, focusing on regulated markets such as the US and Europe.

Centaur Pharmaceuticals ranks among India’s few, fully integrated pharmaceutical firms with proficiencies across the pharmaceutical value chain. Centaur leverages its synergies across API, R&D, CRAM, Clinical Research and formulations to provide end-to-end solutions to prestigious pharmaceutical partners.

Century Pharmaceuticals Ltd is a privately held Pharmaceutical Company based out Vadodara, India. For more than 30 years, we have emerged as a respectable name in the industry. Our services include manufacturing APIs, facilities for contract manufacturing, Biotechnology research, API research, stability studies, and more.

Concord Biotech Limited is an R&D based Biotechnology company, having focus on the fermentation, semi-synthetic and synthesis based products. Since its inception in 2000, Concord has recorded an excellent growth through diversification and process improvements. Having state-of-the-art US FDA & EUGMP approved facility; Concord is a professionally managed globally recognised supplier of fermentation based API’s and enzyme & offers services in biotechnology area like strain improvement & contract fermentation/ manufacturing. The existing portfolio of products includes API’s in the immunosuppressant, antibiotic, Oncology , Anti-Obesity, hypolipemic segments and enzymes. However, with the expertise in the field of biotechnology and chemistry, the R&D team at Concord is working towards adding new products to the product basket.

They are building a molecular oncology facility with a fully equipped laboratory, integrated process platforms, an in-house bioinformatics team, and a huge genetic database for precise and updated reporting

Dishman is a global, dynamic group of companies offering a continuum of services to the pharmaceutical industry. We are a global outsourcing partner for pharmaceutical companies, offering a portfolio of products and development, scale-up and manufacturing services. The Dishman Group continually invests in the pharmaceutical industry, ensuring Dishman’s businesses can provide pharmaceutical customers with high-value, high-quality products and services today and in the future. Our focus is to add value to the global pharmaceutical industry by serving as a reliable partner. Our business is successful only when our customers are successful.

Recognized as the 'Most Innovative Biotech Company, 2024', by Fast Company! Even today Early R&D, Precision Diagnostics and Translational Biomarker teams spend about 80% of their time wrangling data. Elucidata's mission is to empower scientists in the life sciences field by reclaiming every valuable hour for their research endeavors. Elucidata’s data harmonization platform - Polly, helps research teams make multi-modal biomedical data Machine Learning ready. Each dataset on Polly is processed consistently using pipelines of your choice, is custom curated with granular annotations and undergoes robust QA/QC checks to ensure highest data quality standards. Polly transforms multi-modal and multi-source biomedical data (Omics, Assay, Real World Data, Clinical & EHR Data, and CRO data) into a Unified Data Model. With our 10X faster LLM-powered curation and human-in-the-loop model to achieve 99.99% accuracy, we are fast-tracking time to analysis. Today, Polly is facilitating use case like patient stratification, biomarker discovery, target ID & validation, data management, and development of clinical and commercial pipelines across Pfizer, Janssen Pharmaceuticals, NextGen Jane and IMBDx and over 35 premier biopharma companies and research labs. Head-quarted in San Francisco, we are a 120+ multi-disciplinary team of experts based across the US and India. In September 2022, we raised $16 million in our Series A round led by Eight Roads and F-Prime along with our existing investors Hyperplane and IvyCap. Write to us at info@elucidata.io for queries To talk to us, visit: https://www.elucidata.io/book-a-meeting For more information, visit: https://www.elucidata.io/ Visit Our Offices - San Francisco Head Quarters: 114 Sansome Street, Suite 250 San Francisco, CA 94104 Boston Office: 625 Massachusetts Avenue Cambridge, MA 02139 R&D Hubs, India - Delhi and Bangalore

Epygen Biotech private limited is a Biotechnology organization promoted by the founders of Epygen Labs, bringing along decades of precious experience in Biotech research and successful business. With offices, labs and manufacturing facilities in Dubai, India and USA, Epygen Biotech exhibits unique capabilities in the Biotechnology field, where it has developed a strong pipeline of therapeutic proteins for Cardiovascular, Oncology and Immune disorders. With focus on Biosimilars and Novel Biologic Entities, Epygen utilizes its skills in molecular biology, fermentation and protein engineering to produce Biologics in an affordable way, meeting global regulatory standards.

Fibroheal Woundcare Pvt Ltd is a startup approved under Startup India and Startup Karnataka and winner of National Technology Award under startup category & working on leveraging biomaterial property of silk to innovate and develop various biomedical application of silk proteins to address different healthcare needs. we are supported by by DBT, Government of India, Center for cellular and molecular platforms (CCAMP) and Department of IT,BT and ST, Govt of Karnataka. We work on Bio Modified silk proteins to develop various innovative medical devices / other products for Advanced and Active wound care management addressing non healing, slow healing and difficult to heal acute and chronic wounds. We have been recognised by BIRAC for our innovation and commercialising a patented product from Silk Protein which assists in faster healing of wounds through higher scaffold formation and tissue regeneration. We aspire to be a comprehensive Woundcare company addressing various types of wounds and make a difference with our unique meaningful science. Look forward to make a difference in woundcare space and passing on the benefits of economic multiplier potential of Silk and silk proteins to the masses while being most comprehensive woundcare company from India.

A Public limited firm in the business of manufacturing and supply of High quality Generic Active Pharmaceutical Ingredients (APIs) to the Global Pharmaceutical Industry since 1995.

GangaGen Biotechnologies Private Limited, India (GBPL), is a biologics company specialized in discovering, designing and developing novel treatments for drug-resistant bacterial infections. The company is focused on developing products for the prevention and treatment of bacterial infections, including pneumonia caused by multidrug-resistant bacteria. GangaGen is a clinical-stage biotechnology company with a focus on developing novel therapeutic proteins.

GenePath Diagnostics is a next generation molecular genetics company that provides state-of-the-art clinical in vitro diagnostic services for developing markets and is developing novel next generation diagnostic tests and platforms for the global market. We are an innovation-centric company with a strong emphasis on continuous R&D. We are constantly evolving in pace with global developments in the field and have the ability to develop new tests where needed, e.g. to respond to an emerging pathogen or a rare genetic disorder. We pride ourselves on our ability to work with clinicians to come up with novel or custom solutions to diagnostic problems. At GenePath, we strongly believe in our culture. Our company’s values are the principles and ideals that we live by.

Geno has the W .H.O. - G.M.P. approved facilities at Mapusa, Goa to manufacture Tablets, Capsules, Syrups and Ointments in the Plant extending over 5 acres of area. Geno is now an ISO 9001:2008 certified company with revised schedule M compliance.

Established in Hyderabad, India in 1978, Gland Pharma is one of the fastest-growing small-molecule generic injectables-focused company, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets in the rest of the world. Gland Pharma has seven manufacturing facilities in India, comprising four facilities for finished formulations and three API facilities. We are focused on meeting diverse injectables needs with a stable supply of affordable and high-quality products. We have established a portfolio of injectables products across various therapeutic segments and delivery systems and are present in sterile injectables, oncology and ophthalmics with a focus on complex injectables.

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark's culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark's core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation' (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

ImmunoScience India Pvt. Ltd. is a pioneering In-vitro Diagnostics (IVD) company dedicated to improving health care with cutting-edge diagnostic technologies. With an emphasis on precision, reliability, and innovation, we aim to provide healthcare professionals with tools that improve patient care and outcomes. ImmunoScience India is an ISO 13485 and ISO 9001 accredited company formed in 2009 with a state-of-the-art manufacturing facility spanning six acres and located approximately 15 kilometers from Pune. The manufacturing facility can manufacture 25000 IVD tests each shift and 2000 uncut sheets for OEM services per shift. The organization manufactures an array of infectious disease tests in rapid, latex and turbilatex and ELISA formats, covering HIV, HBV, HCV, Dengue, Malaria, Typhoid, Leptospira, autoimmune disorders and many others. We prioritize hiring locally to capitalize on the skills and talents available in the communities where our manufacturing facility is located. We invest in training and development programs to empower local workers with the necessary skills and expertise to excel in their roles. By employing local workers, we not only contribute to job creation and economic growth but also foster a sense of ownership and pride in the products they help produce.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business. Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK. Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products. Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies. The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab. Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.

Ions Pharma is is involved in Manufacturing and trading of pharmaceutical API's ,veterinary API's, Food chemicals, Food additive, Excipients.

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Jubilant Biosys Ltd (JBL) offers end-to-end CRDMO solutions in Structural Biology, Computational Chemistry, Medicinal & Synthetic Chemistry, in-vitro and in-vivo Biology, DMPK, Toxicology, Process R&D & Manufacturing to various Biotech & Pharma companies pursuing drug discovery, development and manufacturing. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Pharmova, serving the global life sciences, agrochemicals and specialty chemicals industry through its research centers & manufacturing facilities in India. Jubilant's services in discovery research include; Jubilant's services in discovery research includes; • Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain and Inflammation. • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.

Laurus labs is an innovation-driven¸ people-centric & client-focused organization offering a broad and integrated portfolio of products & services to the global pharmaceutical industry. Equipped with a world-class infrastructure manned by best-in-class personnel & driven by the core values of knowledge, innovation and excellence, within a relatively short period, Laurus labs emerged as a segment-leading manufacturer of high quality APIs, a preferred partner for NCE development & manufacture & a trusted source of specialty ingredients for the nutraceutical industry. Given the strengths, capabilities & experience, Laurus Labs is uniquely positioned to help its clients in their endeavor of ‘quicker to market' & thus contributing towards improving access to quality & affordable healthcare worldwide.

Lazuline Biotech Private Limited is a research-driven and quality-focused biomanufacturer with a focus on improving the human health by catering to the needs of the healthcare and biopharma industries. Our world-class R&D and cGMP manufacturing facility in Hyderabad, India has enabled us to develop a range of Recombinant and Biological products. Founded in 2011, through the years we have been able to differentiate ourselves with our product-oriented focus and global partnerships. Through continuous innovations and single-pointed focus, we are proud to be producing the highest capacity in the world at economical pricing for the global market.

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 22,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Mapmygenome™ uses genomics to personalize health and well-being. Our at-home DNA tests and diagnostic genomic tests provide DNA-based insights that enable consumers, physicians, and health service providers to create a personalized health journey. Established in 2013, Mapmygenome™ has a vision to “Touch 100 million lives and save a million lives by 2030. Some of the preventive genomic tests that Mapmygenome™ offers are Genomepatri, BeautyMap, MyFitGene, Cardiomap, MedicaMap, and MapmyBiome. MapMyGenome also helps people discover their ethnic roots with Genomepatri Heritage.

MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. MedGenome Inc. has its Corporate Headquarters and a Next Generation Sequencing (NGS) lab in Foster City, California, US. MedGenome Labs is the market leader for genetic diagnostic testing in India and South Asia. We deliver AI-driven and Validated Genetic testing solutions through new-age proprietary tools and technologies to empower the Clinicians for better management of disease cohorts in rare inherited diseases, reproductive genetics, cancer, eye & neurological disorders, diabetes, cardiovascular diseases and more. Our Genetic Reference Lab at Bangalore is the largest CAP accredited lab in South-East Asia, that offers over 1300 genetic tests across different disease areas such as Oncology, Neurology, Cardiology, Ophthalmology and Rare diseases.

Meril's core objective is to design, manufacture and distribute clinically relevant, state-of-the-art and best-in-class medical devices to alleviate human suffering and improve quality of life. We thus have a strong commitment towards R & D and adherence to best quality standards in Manufacturing, Scientific Communication and Distribution known today. Origin Established in 2006, Meril was launched in line with the health-care diversification plan by a large format Indian multi-national company. Disclaimer: Information on Meril Digital / Social Media platform is not intended to be a substitute for professional medical advice, diagnosis or treatment. Meril does not recommend self-management of health issues. For more information, visit: https://www.merillife.com/disclaimer

Metrochem API is one of the fastest growing manufacturers of Active Pharmaceutical Ingredients (APIs), Pellets (Semi finished Formulations) and Intermediates in Multi Therapeutic segments like Antiulceratives, Antifungals, Antidepressants, Antihypertensives, AntiThrombotic, Antihistaminic, Antilipemic, Antiarthritic, Antiinflammatory, Antidiabetic, Antibacterial, Gastoprokinetic. We have total Six State- of- the-Art production facilities based in Hyderabad & Vishakapatnam, India. To cater our customer high volume requirements, we have dedicated each of our 6 manufacturing facilities to our 3 core product groups – APIs, Pelletization& Intermediates – reinforeced by a well equipped, centralized Research & Development laboratory. Our facilities are ISO 9001-2008, WHO: GMP, USFDA, Cofepris and Japanese Accredited approved. Inspected by KFDA authorities and awaiting for certification andmoving towards EUGMP, MHRA &TGA in 2015. Metrochem API management team having of top notch professionals, with extensive experience in Organic chemistry. Our most valuable resource is its people, It is a Knowledge driven company with dedicated professionals at the helm handling operations in Research & Development, Production, Quality Assurance, Marketing, Supply Chain and Finance.

With over two decades of experience in Big Data and Data Science Solutions, Molecular Connections (MC) has been using AI-powered proprietary models to help customers achieve digital transformation. We have been able to successfully build a data-driven decision-making strategy for our customer’s digital transformational journey. MC leverages AI, ML and the Linked Data Store to build efficiencies in various verticals and generate new revenue streams for its customers. MC’s decades of industry presence and a strong focus on innovation have led us to work with the world’s leading pharma and STEM industries to offer end-to-end software development and data insights powered by proprietary workflows and platforms, enabling content engineering across multiple domains. With over 70% of its workforce being women, MC is ranked among the top 15 best companies for women to work for in India. Subsidiary Companies: 1. Molecular Connections Analytics Pvt. Ltd. | URL: https://mcanalytics.co.in/ 2. Molecular Connections Research Pvt. Ltd. | URL: https://mcresearch.co.in/

Morepen Laboratories Limited is an Indian pharmaceutical company founded in 1984. It focuses on providing affordable and high-quality healthcare solutions through innovative pharmaceutical and medical technology products. The company is committed to excellence and aims to make health accessible worldwide. Morepen offers a diverse range of products, including high-quality Active Pharmaceutical Ingredients (APIs) such as Loratadine and Atorvastatin, as well as formulation products across various therapeutic categories like antibiotics and analgesics. The company also has a strong presence in the medical devices sector, particularly with its Blood Glucose and Blood Pressure Monitors. Morepen operates three manufacturing plants in Himachal Pradesh, India, and has a well-equipped R&D center that emphasizes innovation. With a robust distribution network of over 5,100 distributors and 328,000 retail touchpoints in India, Morepen exports its products to more than 50 countries, establishing itself as a significant player in the global generic drug market.

Outsourcing

MSN Group is one of the fastest-growing, research-based and fully integrated pharmaceutical companies based out of Hyderabad, India. It was founded in the year 2003 with a mission to make high-quality medicines affordable and accessible to the world. The organization presently has 22 state-of-the-art manufacturing facilities (15 API and 7 Finished Dosage Facilities) established across India and USA. The group has an integrated R&D centre that facilitates the research of both API and Finished Dosages under one roof, enabling the organization to introduce new and affordable therapies in global markets swiftly. Backed by a dedicated and experienced team of over 14,000 qualified professionals, the organization has earned a global distinction for its innovation, quality and speed of delivery besides achieving the following: > About 900+ national and international patent applications filed > Product portfolio of 450 + APIs & 300+ Finished Dosages > Over 35 major therapeutic offerings covering Oncology, Cardiology, CNS, Diabetes, Nephrology, Urology, Gastroenterology, Orthopaedics etc. > World No. 1 in active US DMF Filings > Won the trust of more than 40 Million patients across 100+ countries The organizational environment at MSN Labs integrates multiple disciplines and functions by effective implementation of goals and objectives through technology coupled with Integrity, Imagination and Innovation. The company's proactive marketing, robust IP strategy, innovative R&D expertise, dynamic SCM, Insight-driven IT, and world-class facilities remain at the heart of its continuing success. We own a track record of growing at an exponential pace since our inception. From 22 Million USD in 2005 to achieving about 670 Million USD turnover in FY 2021-22 and counting, we continue to expand our growth and global footprint by creating innovative solutions for tomorrow's healthcare requirements.

Neuland Laboratories is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end chemistry-related solutions provider for the pharmaceutical industry. With three FDA-inspected facilities, 846+ DMFs, 1000+ employees and customers in more than 85 countries, Neuland supports some of the world's best-known and most successful pharmaceutical research and manufacturing companies. The spirit of research and professionalism pervades Neuland's corporate culture. Neuland's manufacturing capabilities and competence in complex chemistry provides reliable and superior quality products and services. Neuland is a leading manufacturer of APIs and provides customers with: * Contract research, contract manufacturing and generic APIs * 75 API's in 10 diverse therapeutic areas * 3 regulatory approved manufacturing facilities * 40,000 sq. ft. state-of-the-art R&D facility in Hyderabad * 300 + scientists working in R & D * Listed on the Bombay Stock Exchange and National Stock Exchange * Worldwide compliant facilities (WHO, US FDA, EMA, PMDA, TGA, KFDA, ANVISA, ISO 14001, ISO 27001 and OHSAS 18001 Certified) Neuland's core strategy is to never to compete with its customers. Neuland focuses purely on serving the global pharmaceutical firms with API manufacturing, and contract research & manufacturing services.

We are Nexstem. We create Brain-Computer Interface (BCI) solutions that help people interact with technology using their brain signals. Founded in 2020, by Siddhant and Deepansh - engineers with a passion for neuroscience and technology, we've been pushing the boundaries of what's possible in neurotech since our first product, the Nexstem V1 in 2022. At Nexstem, we specialize in non-invasive BCI devices, like our 19-channel headset, Instinct, which comes with a full software ecosystem to decode brain signals. Our goal is to make BCI technology accessible, empowering researchers, clinicians, and developers to innovate and explore new frontiers in brain-computer interaction. Nexstem's technology is recognised by many stalwarts of the industries includes Mircrosoft for Startups, NASSCOM, VIVA tech Paris, YourStory and many more. We have got support from some of the finest neuroscientists and doctors to build accessible tech for the neurotech. We strongly believe in creating value for people and NeuroTech Pulse is our monthly news letter that highlights a news round-up of neurotech industry across the globe, events, case studies and individual spotlights for notable achievers in the field. Do join us on substack - nexstem.substack.com

Piscium Health Sciences Pvt. Ltd., is proud to be at the forefront of the dental and medical devices industry, driving innovation and addressing common dental problems with cutting-edge technologies. Our mission is clear - to revolutionize dental care through breakthrough innovations. 🔬 Recognized for Excellence: Our commitment to excellence is evident through our state-of-the-art R&D facility, acknowledged by the DSIR. We have also been certified by ISO 13485:2016, a testament to our dedication for maintaining the highest quality standards in our products. 💡 Powered by Collaboration: We owe our success to the incredible support from prestigious institutions like SINE and the IITB-Monash Research Academy within IIT Bombay. Their incubation and backing have been instrumental in propelling our vision forward. 🏆 Acknowledged for Impact: Pioneering dental device development is in our DNA, and it's gratifying to be recognized for our efforts. The grant aid received from BIRAC, under the Department of Biotechnology, Govt of India, further validates our commitment to driving positive change in dental care. 🌟 Introducing Alpha Nano-Diamond Bur: One of our standout innovations is the groundbreaking Alpha Nano-Diamond Bur - a patented dental bur that ingeniously combines carbide and lab-grown synthetic diamond for unmatched cutting efficiency and precision, setting new standards in dental care. 🌐 A Vision for the Future: Our mission goes beyond individual products. We aspire to build a diverse portfolio of dental and medical devices that empower healthcare professionals and positively impact the lives of patients worldwide. Join us in our journey to transform dental care! #PisciumHealthSciences #InnovationInHealthcare #DentalDevices #MedicalDevices #HealthcareRevolution

At PlatinumRx, we are revolutionizing the pharma industry with transparency and affordability. Empowering you with the best medicine choices at unbeatable prices. Breaking barriers in healthcare, we're not just another e-pharmacy; we're a movement towards informed, cost-effective health solutions. Join our journey!

Premas is developing transformational technologies and partnering with pharmaceutical companies around the world to expedite their drug discovery programs by cutting down significantly both on costs & time to clinics. Axtex-4D, a three-dimensional cell culture platform, engineered to produce high-throughput screens for targeted immuno-oncology drug candidates, is compelling scientists to relook at their tumor-targeting strategies. The ex-vivo culture systematically mirrors the in-vivo tumor microenvironment and is poised to revolutionize both drug discovery & combinatorial therapies. D-Crypt, a platform for 'difficult-to-express' proteins, is designed to considerably reduce time, cost, and risks associated with producing high-quality recombinant proteins. D-Crypt combines a yeast expression host with over 20 custom-made expression vectors. C-Qwence, our naive India-based Antibody Library is harnessing the power of a genetic pool that is more diverse than any other region and has exposures to infectious diseases and changes in an environment not seen in Europe or America. C-Qwence captures a wealth of novel genetics and protective immune responses, demonstrated in the unique profiles of individual antibodies isolated from the libraries. Combining our breakthrough technologies with state-of-the-art Gene to IND biologics development capabilities, Premas is seeking new partnerships with pharmaceutical companies to help accelerate the delivery of new medicines to patients.

PREMIER Biosoft is a leading bioinformatics company offering software products and services to government agencies, pharmaceutical and biotechnology companies and academia across the globe. PREMIER Biosoft specializes in software development for life science community. and has products for PCR, Real Time PCR, Mass spectrometry data analysis, Glycomics, Lipidomics, MALDI Imaging, Proteomics and Plasmid drawing. The company also offers custom informatics solutions to life science companies and laboratories. With all these services, the PREMIER Biosoft team promises to extend these benefits to companies, universities and laboratories.

Qure.ai is a breakthrough Artificial Intelligence (AI) solution provider that is disrupting the radiology 'status quo' by enhancing imaging accuracy and providing AI assistance for Accelerated Healthcare. The company uses deep learning and AI to make healthcare more accessible and equitable for patients. Qure AI also provides automated interpretation of radiology exams and ultrasound scans, and has raised a total funding of $56M over 5 rounds from healthcare investors.

RASA is a CRO offering solutions and services in the area of Life sciences. With our combined experience in Bio-informatics and Chemo-informatics and strong advisory board, RASA is set to provide premium services in technology solutions, product development and training. We provide our customers with a seamless model of our wide expertise and comprehensive platforms. We are one of the emerging Bio-IT company based in Pune dealing with broad aspects of life science informatics such as Next generation sequencing, Bioinformatics, Drug discovery, Biological database development, Data curation, etc. Being able to achieve success since our establishment, we are always dedicated to improve our quality of service and bring out best suitable results for you and evolved with best name in the field of life science. We would like to approach for possible collaboration with regards to data curation and other related BIO-IT services such as biological database development, software and data analysis. If your company outsources any of these services, we would like to present ourselves and would like to be part of your growth.

String's purpose is to commercialize next generation ingredients that enable sustainability and traceability in evolving value chains. String Bio is in the business of manufacturing raw materials for Animal Nutrition, Agriculture, Human Nutrition and Personal Care sectors that are derived using a sustainable and traceable process. String, as one of the world leaders in gas fermentation, has a strong IP protected platform called SIMP (String Integrated Methane Platform) that enables production of high quality ingredients using methane. Our proprietary platform leverages advances in synthetic biology, fermentation technology, chemistry and process engineering. Our mission is simple: To innovate at the cutting edge of biology, engineering and chemistry to enable sustainable and scalable solutions in sectors that are fundamental to living. - Our impact is in enabling localized manufacturing that provide economically competitive alternatives. - Our impact is in leveraging the carbon in greenhouse gases to build strong value chains. - Our impact is in enabling safe, organic and natural options. - Our impact is in enabling inherent circularity in living.

Welcome to Suraksha Diagnostics! We offer a one-stop integrated solution for pathology and radiology testing, along with medical consultation services. Our comprehensive services are designed to meet the diverse diagnostic needs of our customers, supported by our extensive operational network. Our Strengths: Heritage and Growth: With a strong operating history and a dominant position in our core geography, we continue to expand our business across Kolkata, the remaining east Indian, and adjacent north-east Indian markets. We leverage our extensive network and reputation for quality to capture the growing opportunities in these regions. Technology: Our diagnostic centres are equipped with state-of-the-art radiology and pathology equipment from leading global brands like HORIBA, Schiller Healthcare India, Beckman Coulter, Siemens Healthineers, and more. Our technology is supported by a team of skilled laboratory doctors, radiologists, and technical staff who ensure the highest standards of diagnostic accuracy and reliability. Superior Quality Commitment: We prioritize a customer-centric approach, leading to high satisfaction and retention rates. Our value-added services include home sample collection, house calls, and multiple report delivery options via SMS, email, and web portal, ensuring convenience and accessibility for our customers. Neighbourhood Polyclinics: Many of our diagnostic centres feature associated polyclinics where patients can consult with specialist doctors across various fields, including general physicians, pediatricians, gynecologists, surgeons, cardiologists, neurologists, and more. This integrated approach ensures comprehensive care under one roof. Website https://www.surakshanet.com/ Phone (033) 66191000 Industry Hospitals and Health Care Company size 1,001-5,000 employees Headquarters Kolkata, West Bengal Founded 1992 Specialties Diagnostics, Healthcare, Medical Diagnosis, Pathology, Radiology, and Poly Clinics

Telluris Biotech India Private limited is involved in developing solutions to important issues plaguing the agricultural and food processing industries.They are currently developing alternatives to combat the plant parasitic pathogen, root knot nematode Meloidogyne incognita. Root knot nematodes account for about 12.3% crop loss globally that is in the range of $167 billion and in India the losses are in the range of Rs. 21,068.73 million annually. The major crops affected in India are capsicum, tomato, chilli, okra, gherkins, muskmelon, watermelon, carnations, roses, gerbera and anthuriums. Nematode problems in these crops have reached an unprecedented level, wherein a loss of about 80% in crop yield has been reported in crops grown in protected conditions. It has also been reported that, nematode infestation makes the crop more sensitive to fungal infestations which leads to an increased crop loss.

Tenshi Kaizen(TK or Tenshi) is focussed on delivering advanced finished dosage products driven by proprietary technology platforms, global infrastructure, and a robust quality system. Our strategy is aligned with the founder's ethos of producing reliable and cost-effective pharmaceuticals with speed and agility. As of today, Tenshi Kaizen has investments in three proprietary technology platforms viz. InstaPillTM technology for rapid dissolve tabs, the world's first thermostable probiotics platform(Under Triphase) , and proprietary technology to extract and develop highly bioavailable natural products(Under Olene Life Sciences) Building on our strong global network, we are committed to fulfilling the demands of the world markets by anticipating the future needs and pioneering strategic new in-roads into the commercial pharmaceutical sector. Please visit www.tenshi.co.in

THINQ is a totally vertically integrated service and product provider for pharmaceutical companies offering the below services: - Contract R&D Contract Manufacturing - API Development, Manufacturing and Marketing - Formulation Development & Marketing

Transcell Biologics is an innovative biotech company with continuous discovery and process development as it's central theme to deliver unique disruptive stem cell based solutions to treat chronic and debilitating diseases that have otherwise no options available to manage. The passionate leadership team is committed to developing therapies to address important medical needs through adult stem cell technologies by collaborating with clinicians and patient communities. Among the company's landmark innovations is the development of a novel proprietary process for maximizing the therapeutic stem cell yield that also maintains the native pluripotent properties and inherent functionality. The Company has evolved from solely an R&D-focused biotech entity diversifying based on the intended applications of stem cell technologies.

Since 1997, the journey of Trivitron Healthcare as a medical technology company providing affordable healthcare solutions has woven a fascinating thread of inspiration to many healthcare providers. Having solid expertise in research and development, Trivitron manufactures and distributes exceptional medical technology products to 180+ countries. With 15 certified manufacturing facilities in India, USA, Finland, Turkey & China; Trivitron spearheads innovation in the fields of In-Vitro Diagnostics, Imaging & Radiology, Radiation Protection, Newborn Screening, Critical Care & ICU Solutions and Renal Care Portfolio, thus, engraving its name as a holistic healthcare provider. 15 Manufacturing Facilities | Presence in 180+ Countries | 100,000+ Customer Base To learn more, visit www.trivitron.com

Burden of medicine bills is a leading cause of financial worry among Indian consumers ● 70% of healthcare spend in India is on Medicines ● 15-20% of family income of chronic patients is spent on medicines ● 63 million people in India plunge into poverty annually due to healthcare costs Our vision is to make healthcare affordable and accessible to all. We are a technology driven, tele-health platform that aims to reduce healthcare expenses and improve healthcare outcomes by democratising medicine purchase in India. Truemeds, through its proprietary algorithm and tele-consultation, is able to recommend best value medicines to customers with precise scientific matching and outcomes history leading up to 51% savings for customers! We have grown at a phenomenal pace with customer love – 60X growth delivered in last 20 months. Headquartered in Mumbai, we are excited to build a strong product and operations team, which is passionate to build innovative solutions and willing to go the extra mile to ensure the customer has the best experience.

Turtle Pharma is a Private Pharmaceutical Company, with Headquarters in Mumbai, and Plant located near Vadodara, Gujarat, engaged in manufacturing of Active Pharmaceutical Ingredients. Turtle Pharma Private Limited Our main aim is to manufacture Active Pharmaceutical Ingredients, in conformity with regulations in force concerning the quality of pharmaceutical products, environment, safety and the health of consumers and citizens.

Vivo Bio Tech is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of custom research, In-vitro and In-vivo toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies The company's state-of-the-art ‘preclinical research facility' spreads over 125,000 Sq.ft designed and built in compliance with Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) and Good Laboratory Practice (GLP) guidelines. The facility is CPCSEA registered and AAALAC International accredited

Vopec Pharmaceuticals Private Ltd. is a pioneering company which is manufacturing Ayurveda and siddha formulations, and was established in the year 1996. Vopec pharma has taken up a leading role in the formulations re-establishing ancient knowledge with modern Research and manufacturing techniques. The company is located in Aminjikarai, Chennai having GMP Certificate and FSSA licence to manufacture nutraceuticals. Vopec also have licence to manufacture Ayurvedic and Siddha formulations including Sasthric products and Food supplements. Vopec is a stake holder in Traditional Ayush Cluster of Tamilnadu (P) Ltd., precisely called TACT. Vopec Pharmaceuticals has various herbal capsules, syrups and pain relieving oils like Nart Capsule, Asmask Capsules, Dyzee Syrup etc. Another exciting program that Vopec provides are the consultation slots with Ayurveda experts, where one can mention their problems or issues and get effective solutions within minutes.

Provides extraction and diagnostic kits.COVID-19: WobbleBase Bioresearch Pvt Ltd is introducing CovidXtract, a completely ‘Made in India’ Viral RNA extraction kit to facilitate scalling up the testing of COVID-19 in india. This kit is designed to facilitate Mass screening by minimum TAT and without need of any special infrastructure for extraction.

Xcelris is India's leading genomics research organization offering cutting edge solutions to researchers across fields such as agriculture, human health, animal science, wildlife conservation, bio-energy, microbial and environmental genetics.